Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Investors Bet AstraZeneca Megamerger Could Live Again
Bloomberg
Friday, August 29, 2014 - 3:04pm
tags:
M&A, AstraZeneca, Pfizer
Boston Scientific Wins Second Mesh Trial, Lawyer Says
Bloomberg
Friday, August 29, 2014 - 2:59pm
tags:
devices, Boston Scientific, Obtryx
Covidien Acquires Venous Disease Cure Developer
Yahoo/Zacks.com
Friday, August 29, 2014 - 2:53pm
tags:
Covidien, M&A, venous disease, Sapheon
Two Silicon Valley Health-Tech Startups Win Hard-Fought FDA Approval
Silicon Beat
Friday, August 29, 2014 - 2:51pm
tags:
heart monitors, devices, FDA, AliveCor, Vital Connect
4 Biotechs That Might Be Bought Soon
Investors.com
Friday, August 29, 2014 - 2:47pm
tags:
M&A, Achillion, Intercept Pharma, Puma Biotechnology, Receptos
Experimental Ebola drug ZMapp cures 100 percent of lab monkeys
Yahoo/Reuters
Friday, August 29, 2014 - 2:44pm
tags:
ZMapp, ebola virus, Mapp Biopharmaceutical
United Therapeutics rises as court upholds patent protecting Remodulin, its top-selling drug
Yahoo/AP
Friday, August 29, 2014 - 2:42pm
tags:
United Therapeutics, patents, Remodulin
Why J&J Wants to Divest Medical Devices Business
Yahoo/StockTwits
Friday, August 29, 2014 - 2:41pm
tags:
JNJ, Cordis, M&A, devices
Biotech Analyst Optimism: Price Targets Post-IPO
Forbes
Friday, August 29, 2014 - 11:16am
tags:
IPOs
Germany's Bayer to launch three new Xarelto trials
Yahoo/Reuters
Friday, August 29, 2014 - 10:18am
tags:
Bayer, Xarelto, clinical trials
Aspen Shares Climb After Drugmaker’s Earnings Growth Quickens
Bloomberg
Friday, August 29, 2014 - 10:15am
tags:
Aspen Pharmacare, earnings
Is Pfizer now eyeing up Actavis three months after failed AZ bid?
In-Pharma Technologist
Friday, August 29, 2014 - 8:12am
tags:
M&A, Actavis, Pfizer, AstraZeneca
Has Gilead Sciences, Inc.'s Star Drug Already Peaked?
Motley Fool
Friday, August 29, 2014 - 8:10am
tags:
Gilead Sciences, Sovaldi, hepatitis C
AstraZeneca buoyed by Pfizer takeover talks, colorectal cancer study for MEDI-4736
First Word Pharma
Friday, August 29, 2014 - 8:07am
tags:
colon cancer, AstraZeneca, Pfizer, M&A, MEDI-4736
Report: In a big split, Baxter looks to relocate biopharma to Boston
Fierce Biotech
Friday, August 29, 2014 - 8:04am
tags:
Baxter International, Boston
IRS struggles with device tax
Medical Marketing and Media
Friday, August 29, 2014 - 8:02am
tags:
device tax, devices, IRS
Eli Lilly and BI's Jardiance hits shelves
Medical Marketing and Media
Friday, August 29, 2014 - 8:00am
tags:
Eli Lilly, Jardiance, Boehringer Ingelheim, diabetes, SGLT2 inhibitor
Will Seattle Genetics (SGEN) Crush Estimates at Its Next Earnings Report?
Yahoo/Zacks.com
Friday, August 29, 2014 - 7:58am
tags:
Seattle Genetics, earnings
Johnson & Johnson Said Exploring Sale of Cordis Devices Business
Bloomberg
Friday, August 29, 2014 - 7:56am
tags:
JNJ, Cordis, devices, M&A
Consultants expect M&A tempo to continue
Medical Marketing and Media
Thursday, August 28, 2014 - 7:27pm
tags:
M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.